case_images: PMC11810924_01
case_images: MG-ADL total- and item-specific-scores following efgartigimod treatment during the perioperative period. Timeline showing the administration of efgartigimod and associated reduction in MG-ADL score from MG-ADL 19 pre-first dose and preoperatively, to MG-ADL 12 by the end of the first cycle of efgartigimod. Item-specific scores are shown for the MG-ADL scores measured pre-first dose, post-first dose and post-first cycle of efgartigimod.
case_images: fimmu-16-1524200-g001.jpg
case_images: PMC11810924_01_fimmu-16-1524200-g001.jpg
case_images: f1
case_images: She completed a full cycle of efgartigimod treatment (a total of 4 infusions 1 week apart), reaching MG-ADL 12 at the end of the cycle ( Figure 1 ).
case_images: MG-ADL score following 4 cycles of efgartigimod treatment over approximately 10 months. Timeline showing the administration of efgartigimod cycles and associated reduction in MG-ADL score during the perioperative period (in pink) and over the following 9 months. The timeline is not to scale.
case_images: fimmu-16-1524200-g002.jpg
case_images: PMC11810924_01_fimmu-16-1524200-g002.jpg
case_images: f2
case_images: The patient's MG-ADL score continued to improve over 3 more cycles of efgartigimod, reaching MG-ADL 3 after approximately 10 months ( Figure 2 ).